Dicot Pharma AB (FRA:KN0) Total Long-Term Liabilities: €0.00 Mil (As of Mar. 2026)


FRA:KN0 Dicot Pharma AB FRA:KN0
23 GF Score
Price €0.01
! 2 Warning Signs
View Full Analysis

What is Dicot Pharma AB Total Long-Term Liabilities?

Dicot Pharma AB FRA:KN0 -7.24% 23 Total Long-Term Liabilities is €0.00 Mil as of Mar. 2026. GuruFocus rates FRA:KN0 with a GF Score™ of 23/100. The stock has 2 warning signs investors should review.

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Dicot Pharma AB's Total Long-Term Liabilities for the quarter that ended in Mar. 2026 was €0.00 Mil.

Dicot Pharma AB Total Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Dicot Pharma AB's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dicot Pharma AB Total Long-Term Liabilities Chart

Dicot Pharma AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

Dicot Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:KN0
23GF Score
Dicot Pharma AB FRA:KN0
Total Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dicot Pharma AB Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

What does a Total Long-Term Liabilities of €0.00 Mil mean?
Dicot Pharma AB (FRA:KN0) has a Total Long-Term Liabilities of €0.00 Mil as of Mar. 2026. Toal Long-Term Liabilities is the obiligation expected to be repaid beyond the following twelve months or one business cycle. View historical data on Dicot Pharma AB and its competitors.
Is Dicot Pharma AB's Total Long-Term Liabilities too high?
Dicot Pharma AB's current Total Long-Term Liabilities is €0.00 Mil. Overall, Dicot Pharma AB has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Dicot Pharma AB's Total Long-Term Liabilities compare to ZTS?
Dicot Pharma AB's Total Long-Term Liabilities of €0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Long-Term Liabilities for a Drug Manufacturers company?
A good Total Long-Term Liabilities depends on the Drug Manufacturers industry context. However, Total Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Long-Term Liabilities mean?
A high Total Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Toal Long-Term Liabilities is the obiligation expected to be repaid beyond the following twelve months or one business cycle. View historical data on Dicot Pharma AB and its competitors. Dicot Pharma AB's current Total Long-Term Liabilities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dicot Pharma AB stock overvalued right now?
Dicot Pharma AB (FRA:KN0) has a current Total Long-Term Liabilities of €0.00 Mil. The current Total Long-Term Liabilities is €0.00 Mil. Dicot Pharma AB's overall GF Score™ is 23/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Long-Term Liabilities calculated?
Total Long-Term Liabilities is calculated from a company's financial statements. For Dicot Pharma AB (FRA:KN0), the current Total Long-Term Liabilities is €0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dicot Pharma AB Business Description

Other Exchanges DICOT:SwedenKN0:Germany
Address S:t Olofsgatan 11A, Uppsala, SWE, SE 753 21
Dicot Pharma AB is developing a modern potency medicine that will treat erectile dysfunction and premature ejaculation than existing preparations. The business model involves evaluating industrial and financial partnerships during clinical development to bring LIB-01 to commercialization on the world market. The company's drug candidate LIB-01 has a longer duration of action and fewer side effects, and is also used in the treatment of erectile dysfunction and premature ejaculation.
23GF Score

Get the complete analysis for FRA:KN0

Total Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price